BDR Pharmaceuticals

BDR Pharmaceuticals, officially known as BDR Pharmaceuticals Internationals Pvt.

Ltd., is a privately held Indian pharmaceutical company founded in 2002/2003 and based in Mumbai. The company specializes in manufacturing Active Pharmaceutical Ingredients (APIs) and finished formulations for specialty and life-saving medications. With over 15 years of steady growth, BDR has established itself as a recognized player in both domestic and global pharmaceutical markets, operating major manufacturing facilities in Gujarat and Uttarakhand, along with a pellet facility in Hyderabad. BDR Pharmaceuticals offers a diverse range of products and services, focusing on four key therapeutic segments: oncology, critical care, gynecology, and neurology. The company manufactures new fourth-generation medicines for life-threatening diseases and has a portfolio that includes COVID-19 drugs and generic medications. BDR aims to make critical and life-saving medicines accessible to the public at affordable prices, partnering with major domestic pharmaceutical companies to enhance its market reach.